Who
Matthew C. Hill
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Apyx Medical; Chief Financial Officer, PDS Biotechnology; Chief Financial Officer, STRATA Skin Sciences; Chief Financial Officer, Velcera; Chief Financial Officer, Ep Medsystems.
In numbers
- Trades disclosed
- 26
- Buys
- 6
- Sells
- 0
- Bought
- $69K
- Sold
- $0
- Companies
- 5
- Companies where not an officer
- 0
- First trade
- 12 Dec 2006
- Last trade
- 11 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 15 Jun 2026 | APYX Apyx Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —132,066 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | APYX Apyx Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —132,066 at $0.00 | filing |
| 15 May 2025filed 19 May 2025 | APYX Apyx Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 15 Jan 2025filed 17 Jan 2025 | APYX Apyx Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 13 Aug 2024filed 3 Mar 2025 | APYX Apyx MedicalMedical Devices | SEC FORM 4 Bought | $6,7806,000 at $1.13 | filing |
| 13 Aug 2024filed 13 Aug 2024 | APYX Apyx MedicalMedical Devices | SEC FORM 4 Bought | $6,0305,336 at $1.13 | filing |
| 10 Jan 2024filed 11 Jan 2024 | APYX Apyx Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 12 Dec 2023filed 14 Dec 2023 | APYX Apyx MedicalMedical Devices | SEC FORM 4 Bought | $5,4752,500 at $2.19 | filing |
| 5 Jan 2023filed 6 Jan 2023 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —161,200 at $0.00 | filing |
| 13 Dec 2021filed 14 Dec 2021 | PDSB PDS BiotechnologyBiotechnology | SEC FORM 4 Bought | $23K2,500 at $9.00 | filing |
| 13 Dec 2021filed 14 Dec 2021 | PDSB PDS BiotechnologyBiotechnology | SEC FORM 4 Bought | $3,560400 at $8.90 | filing |
| 13 Dec 2021filed 14 Dec 2021 | PDSB PDS BiotechnologyBiotechnology | SEC FORM 4 Bought | $900100 at $9.00 | filing |
| 13 Dec 2021filed 14 Dec 2021 | PDSB PDS BiotechnologyBiotechnology | SEC FORM 4 Bought | $900100 at $9.00 | filing |
| 19 Oct 2021filed 20 Oct 2021 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —202,800 at $0.00 | filing |
| 13 Nov 2020filed 13 Nov 2020 | STRATA Skin Sciencesoption or derivative | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 22 Nov 2019filed 26 Nov 2019 | STRATA Skin Sciencesoption or derivative | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 14 Jun 2018filed 14 Jun 2018 | STRATA Skin Sciences | SEC FORM 4 Bought | $7,1833,646 at $1.97 | filing |
| 14 Jun 2018filed 14 Jun 2018 | STRATA Skin Sciences | SEC FORM 4 Bought | $8,9024,542 at $1.96 | filing |
| 14 Jun 2018filed 14 Jun 2018 | STRATA Skin Sciences | SEC FORM 4 Bought | $3,5331,812 at $1.95 | filing |
| 23 May 2018filed 24 May 2018 | STRATA Skin Sciencesoption or derivative | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.